ArticleClinics (Sao Paulo, Brazil)2024

Liver biopsy-proven non-alcoholic fatty liver disease predicts no impact on antiviral response in patients with chronic hepatitis B.

Miao-Yang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.